“…In summary, A. baumannii can produce resistance to tigecycline through RND efflux pumps (AdeABC, AdeFGH, AdeIJK) ( Magnet et al., 2001 ; Damier-Piolle et al., 2008 ; Coyne et al., 2010b ), MATE family (AbeM) ( Su et al., 2005 ), ABC transporters (MsbA, MacAB-TolC) ( Shilling et al., 2006 ; Batista Dos Santos et al., 2022 ), and MFS efflux pumps (TetA, TetB, TetA(39), Tet (Y)) ( Rumbo et al., 2013 ; Wang et al., 2021 ; Jagdmann et al., 2022 ; Khlaif and Hussein, 2022 ). In addition, A. baumannii also reduces membrane permeability (plsc, abrp, gnaA, abuO) ( Lu et al., 2005 ; Wang et al., 2012 ; Srinivasan et al., 2015 ; Li et al., 2016 ), alters antibiotic targets (rpsJ, trm, rrf, rpoB) ( Ma et al., 2014 ; Beabout et al., 2015 ; Hua et al., 2021 ; Ghalavand et al., 2022 ), produces tigecycline inactivating enzymes (Tet(X) and its variants Tet (X3), Tet(X5), Tet(X6)) ( Moore et al., 2005 ; He et al., 2019 ; Chen et al., 2021 ) and DNA repair pathways (recA and recBCD) ( Kuzminov, 1999 ; Aranda et al., 2011 ) mediating tigecycline resistance.…”